Practice question

Answer the question and get instant feedback.

HardOncologyMetastatic Prostate Cancer / Bone Metastasesmrcp part 1ukmlapaneprescribing safety assessment

A 70-year-old man is diagnosed with metastatic prostate cancer. He is experiencing significant bone pain. His PSA is elevated, and bone scan confirms widespread bony metastases. He is due to start androgen deprivation therapy (ADT). According to NICE NG131, what treatment should be considered alongside ADT for preventing skeletal-related events (SREs) in metastatic prostate cancer?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.